Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.
BACKGROUND/AIMS: A growing body of evidence has suggested that thiazolidinediones (TZDs) potentially reduce the risk of colorectal cancer (CRC). This study aimed to evaluate the effect of TZDs on CRC risk in patients with diabetes mellitus (DM). PATIENTS ..... Read More